Technology

Zealand Pharma

$37.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 4:01 PM UTC today

Why Robinhood?

You can buy or sell Zealand Pharma and other stocks, options, and ETFs commission-free!

About ZEAL

Zealand Pharma A/S American Depositary Shares, also called Zealand Pharma, is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark. The listed name for ZEAL is Zealand Pharma A/S American Depositary Shares.

CEO
Emmanuel Dulac
Employees
179
Headquarters
Soborg, Zealand
Founded
1998
Market Cap
1.51B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.16K
High Today
$37.65
Low Today
$37.65
Open Price
$37.65
Volume
21.48K
52 Week High
$47.67
52 Week Low
$22.00

Collections

ZEAL Earnings

-$0.91
-$0.61
-$0.30
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.88 per share
Actual
-$0.23 per share

You May Also Like

FNDB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure